Concepedia

Ken H. Young

KH

195

Publications

22K

Citations

67

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University Hospital of Basel

Cleveland Clinic

Odense University Hospital

Marqués de Valdecilla University Hospital

Ken H. Young is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and immunology.

ORCID

Top concepts

Publications per year

2006–2024

195

Publications

195

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe et al. · Autophagy · 2016 · 5.9K citations · Full text

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green, Ken H. Young, Carlo Visco et al. · Journal of Clinical Oncology · 2012 · 677 citations · Full text

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov et al. · Blood · 2013 · 671 citations · Full text

Diffuse large B-cell lymphoma

Shaoying Li, Ken H. Young, L. Jeffrey Medeiros · Pathology · 2017 · 611 citations

, , +4

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Mark W. Clemens, L. Jeffrey Medeiros, Charles E. Butler et al. · Journal of Clinical Oncology · 2015 · 414 citations · Full text

Rows per page

1–5 of 195